KRAS Oncogene Connect
  • Saved

WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors

WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors

Source : https://link.springer.com/article/10.1007/s10822-020-00371-5

Here we present WIDOCK, a virtual screening protocol that supports the selection of diverse electrophiles as covalent inhibitors by incorporating ligand reactivity towards cysteine residues into AutoDock4. WIDOCK applies the...

  • Saved

Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries

Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries

Source : https://www.nature.com/articles/s41587-020-00778-3

Current methods used for measuring amino acid side-chain reactivity lack the throughput needed to screen large chemical libraries for interactions across the proteome. Here we redesigned the workflow for activity-based...

  • Saved

Mechanisms of Resistance to KRASG12C Inhibitors

Mechanisms of Resistance to KRASG12C Inhibitors

Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795113/

KRAS is a gene that is commonly mutated in cancer, especially in pancreatic, lung and colorectal cancers. Despite its importance, scientists have for many years been unable to create a...

  • Saved

Computational Biological Modeling Identifies PD-(L)1 Immunotherapy Sensitivity Among Molecular Subgroups of KRAS -Mutated Non-Small-Cell Lung Cancer

Computational Biological Modeling Identifies PD-(L)1 Immunotherapy Sensitivity Among Molecular Subgroups of KRAS -Mutated Non-Small-Cell Lung Cancer

Source : https://ascopubs.org/doi/abs/10.1200/PO.20.00172

PURPOSE KRAS-mutated (KRASMUT) non-small-cell lung cancer (NSCLC) is emerging as a heterogeneous disease defined by comutations, which may confer differential benefit to PD-(L)1 immunotherapy. In this study, we leveraged computational...

  • Saved

Patient with metastatic lung adenocarcinoma in a supraclavicular lymph node and splenic marginal zone lymphoma. Both new diagnoses. Do you treat the lymphoma?